Navigation Links
XBiotech Announces it is Developing Therapy for MRSA
Date:9/4/2013

AUSTIN, Texas, Sept. 4, 2013 /PRNewswire/ -- XBiotech announced today that it has completed discovery and has begun pre-clinical development of a new True Human™ antibody therapy for methicillin resistant staphylococcus aureus (MRSA). The new antibody therapy is expected to be effective at neutralizing drug resistant staphylococcus infection by circumventing key immune evasion strategies of the bacteria, thereby facilitating natural clearance of the bacteria by the patient's own immune system. The Company believes that the therapy could represent a breakthrough in the management of infectious disease. XBiotech reports that the MRSA antibody came out of its True Human™ antibody discovery program for identifying and cloning pharmacologically relevant antibodies from human donors. XBiotech expects this product candidate to enter human clinical trials next year.

One-third of the world's population is believed to have S. aureus bacteria present on or in their bodies (particularly nasal cavities). It is estimated that 2.7% of these cases are MRSA strains which, under certain situations, can cause severe infections such as so called "flesh-eating" disease, necrotizing pneumonia, infective endocarditis, or more commonly impetigo, cellulitis and abscesses. In the US, community acquired MRSA infections have been reported to occur in 25.7/100,000 persons annually, whereas with respect to nosocomial infections, as many as 60% have been reported to be MRSA. Lethal MRSA infections have increased dramatically, killing 30-fold higher numbers of patients in the UK in 2006 compared to just over a decade earlier.

The Company's CEO, John Simard said, "To date, XBiotech has made significant strides on the discovery and development of anti-inflammatory antibodies. We are now truly excited about the possibility of revolutionizing the management of infectious disease through the use of shared natural immunity with True Human™ therapeutic antibodies. Needles to say, we are eager to see this important therapy in the clinic."

ABOUT XBIOTECH
XBiotech is leading the commercialization of biological therapies—including the discovery and development of True Human™ antibodies. The Company's lead product candidate—in Phase III clinical studies—is a novel, breakthrough treatment for advanced colorectal cancer. XBiotech has also developed manufacturing technology to reduce infrastructure needs, lessen capital requirements and reduce lead times for biological drugs, ushering in a new era for cost and development efficiency in the biopharmaceutical industry.

Contact: 
Ashley Otero
XBiotech
info@xbiotech.com
512.386.2930


'/>"/>
SOURCE XBiotech
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. XBiotech to Present at UBS Global Healthcare Conference
2. XBiotech Reports Positive Phase II Interim Analysis Results in Vascular Disease
3. XBiotech Reports Positive Phase II Interim Analysis Results From Type 2 Diabetes Study
4. Mylan Announces Completion of Transdermal Patch Facility Expansion Project in St. Albans, Vt.
5. SanBio Announces The Completion Of Enrollment Of Its Clinical Trial Of Cell Therapy For Chronic Stroke Deficits
6. Ryan & Maniskas, LLP Announces Class Action Lawsuit Against NuVasive, Inc.
7. Hamilton Regional Laboratory Medicine Program Announces Decision to Acquire COPANs WASPLab, the Next Generation Full Laboratory Automation and Digital Bacteriology System
8. IVD Technology Magazine Announces the IVD Business Strategy Conference in San Diego
9. Avanir Pharmaceuticals Announces Settlement of NUEDEXTA Patent Litigation with Actavis
10. Intra-Cellular Therapies Announces Closing of $60 Million Private Placement and Completion of Reverse Merger
11. Encision Announces Death of Chief Executive Officer Fred F. Perner
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... 11, 2017  Hill-Rom Holdings, Inc. ("Hill-Rom") (NYSE: HRC), ... in Las Piedras, Puerto Rico , ... Following a ... sustained minor structural damage, temporary loss of power and ... been completed, manufacturing operations have resumed, and the company ...
(Date:10/4/2017)... Korea , Oct. 4, 2017  South Korean-based ... next-generation CPR training aide "cprCUBE" on Kickstarter. The device ... compression during cardiac arrests with better efficiency compared to ... also offers real-time feedback on efficacy of the compression ... crowdfunding campaign has a goal to raise $5,000. ...
(Date:10/2/2017)... -- AllianceRx Walgreens Prime, the combined central specialty pharmacy and ... manager Prime Therapeutics LLC (Prime), today officially began the ... of new signage at its headquarters in ... few other company-owned facilities across the country. This also ... whom will begin to see the AllianceRx Walgreens Prime ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... Dickinson Insurance and Financial ... financial preparation services, is providing an update on a charitable event that began ... Rescue is a locally recognized nonprofit that provides shelter and care for animals ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... PurhealthRX ... CBD Oil utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD oil will ... and providing a CBD form that can be easily incorporated into liquid products, while ...
(Date:10/13/2017)... ... October 13, 2017 , ... The Visiting Nurse Association (VNA) of Somerset ... of specialty vendors and unique items from across the nation, this holiday-themed event will ... services offered by the VNA. The boutique will be open Saturday, November 4 ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a leader ... been awarded a contract by the Center for Medicare and Medicaid Services (CMS). ... the enterprise use of Agile methodologies in a consistent and high value manner ...
(Date:10/12/2017)... ... October 12, 2017 , ... Planet Fitness, one of the largest ... its plans to open a flagship location in Covington, LA at 401 N. U.S. ... Go store next to Office Depot in the Holiday Square shopping center. Its location ...
Breaking Medicine News(10 mins):